Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CECO ENVIRONMENTAL CORPCECO · Entity 4034 | Director | June 01, 2026 | June 03, 2026 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | November 06, 2024 | November 12, 2024 |
| CONVERGYS CORPCVG · Entity 163096 | Director | November 10, 2017 | November 14, 2017 |
| ESH Hospitality, Inc.NONE · Entity 16193 | Director | December 14, 2016 | December 14, 2016 |
| ROPER TECHNOLOGIES INCROP · Entity 3071 | Director | July 24, 2026 | July 27, 2026 |
| SmileDirectClub, Inc.SDC · Entity 111962 | Director | June 21, 2023 | June 23, 2023 |
| Spirit Aviation Holdings, Inc.SAVEQ · Entity 77286 | Director | November 29, 2024 | December 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CECO ENVIRONMENTAL CORP
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 233,352 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 3,443 · Balance 233,352 F1: Includes grant of 1,228 shares of common stock in lieu of annual cash fees paid to the director. F2: Shares will vest May 15, 2027. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 105,500 |
Reported balance
After 2026-06-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-01 · Purchase · Acquired 20,000 · Balance 105,500 F3: Price reflects the weighted average purchase price for multiple transactions that ranged from $75.00 to $78.75 per share. The Reporting Person undertakes to provide, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes grant of 1,228 shares of common stock in lieu of annual cash fees paid to the director.
F2: Shares will vest May 15, 2027.
F3: Price reflects the weighted average purchase price for multiple transactions that ranged from $75.00 to $78.75 per share. The Reporting Person undertakes to provide, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date November 06, 2024 · Filed November 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,386 |
Ending reported balance
After 2024-11-07 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-11-06 · Gift · Disposed 4,540 · Balance 19,007 Row 2 · 2024-11-07 · Sale · Disposed 3,371 · Balance 15,636 Row 3 · 2024-11-07 · Sale · Disposed 3,250 · Balance 12,386 |
| Common StockSEC Table I · non-derivative | IndirectBy Wife | 0 |
Reported balance
After 2024-11-07 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2024-11-07 · Sale · Disposed 1,000 · Balance 0 |
CONVERGYS CORP
Report date November 10, 2017 · Filed November 14, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 27,994 |
Reported balance
After 2017-11-10 transaction · row 1
1 source rowRow 1 · 2017-11-10 · Gift · Disposed 10,627 · Balance 27,994 F1: Represents a bona fide gift of common shares to a charitable donor-advised fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a bona fide gift of common shares to a charitable donor-advised fund.
ESH Hospitality, Inc.
Report date December 14, 2016 · Filed December 14, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Paired SharesSEC Table I · non-derivative | Direct | 111,100 |
Reported balance
After 2016-12-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-14 · Gift · Disposed 18,042 · Balance 111,100 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 80,005 |
Reported balance
Holding disclosure · report date 2016-12-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 80,005 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F3: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which the reporting person is a fiduciary. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 9,800 |
Reported balance
Holding disclosure · report date 2016-12-14 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,800 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F4: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which the reporting person is a fiduciary. |
| Paired SharesSEC Table I · non-derivative | IndirectSpouse IRA | 13,800 |
Reported balance
Holding disclosure · report date 2016-12-14 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 13,800 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. |
| Paired SharesSEC Table I · non-derivative | IndirectSpouse SEP | 18,200 |
Reported balance
Holding disclosure · report date 2016-12-14 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 18,200 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.
F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer.
F3: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which the reporting person is a fiduciary.
F4: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which the reporting person is a fiduciary.
ROPER TECHNOLOGIES INC
Report date July 24, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,423 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Sale · Disposed 6,434 · Balance 7,423 |
SmileDirectClub, Inc.
Report date June 21, 2023 · Filed June 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 336,318 |
Reported balance
After 2023-06-21 transaction · row 1
1 source rowRow 1 · 2023-06-21 · Sale · Disposed 135,135 · Balance 336,318 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4237 to $0.4500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1 to Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4237 to $0.4500, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1 to Form 4.
Spirit Aviation Holdings, Inc.
Report date November 29, 2024 · Filed December 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,513 |
Reported balance
After 2024-11-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-11-29 · Sale · Disposed 2,000 · Balance 28,513 F1: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Extended Stay America, Inc.
Report date May 13, 2021 · Filed June 21, 2021
Section 16 reporting ended · disclosed 2021-06-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Paired SharesSEC Table I · non-derivative | Direct | 0 |
Last balance in matching sequence
After 2021-06-16 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-05-13 · Disposition to issuer · Disposed 139,116 · Balance 8,968 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares. Row 2 · 2021-06-16 · Disposition to issuer · Disposed 8,968 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-16 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-06-16 · Disposition to issuer · Disposed 60,005 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F4: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-16 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-06-16 · Disposition to issuer · Disposed 9,800 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F5: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which he is a fiduciary. |
| Paired SharesSEC Table I · non-derivative | IndirectSpouseIRA | 0 |
Reported balance
After 2021-06-16 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2021-06-16 · Disposition to issuer · Disposed 13,800 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. |
| Paired SharesSEC Table I · non-derivative | IndirectSpouseSEP | 0 |
Reported balance
After 2021-06-16 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2021-06-16 · Disposition to issuer · Disposed 18,200 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.
F2: The reported transaction is a bona fide gift of Paired Shares to the Wallman Family Fund, a Fidelity Charitable donor-advised fund. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.
F3: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.
F4: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary.
F5: These Paired Shares are held through the Richard F. Wallman SEP, an individual retirement account for which he is a fiduciary.
Wright Medical Group N.V.
Report date November 11, 2020 · Filed November 13, 2020
Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 1
1 source rowRow 1 · 2020-11-11 · Other · Disposed 12,697 · Balance 0 F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 12,697 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-11 · Disposition to issuer · Disposed 11,691 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-11 · Disposition to issuer · Disposed 9,907 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.86 · Expires 2027-07-25 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-11 · Disposition to issuer · Disposed 10,275 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.24 · Expires 2026-07-19 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-11 · Disposition to issuer · Disposed 11,765 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.20 · Expires 2021-05-12 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-11 · Disposition to issuer · Disposed 7,800 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 12,697 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2021 Filed May 10, 2021 21:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 1,151 | $0.00 Strike: $342.55 | $0.00 |
DisclosureSEC source: 0001127602-21-016117 · form4.xml · derivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires 2031-05-07 F3 · shares: The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 219 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016117 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,289 F2 · shares: The grant was made in lieu of director service fees for the term commencing May 5, 2021. The restricted stock units vest upon the earlier of 5/7/2021, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016117 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,070 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| November 13, 2020 Filed Nov 13, 2020 21:10 UTC | Extended Stay America, Inc. STAY · Entity 16197 | SalePaired Shares | 20,000 | $12.28 | $245,504.00 |
DisclosureSEC source: 0000895345-20-001088 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,084 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.35, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 13, 2020 Filed May 14, 2021 23:36 UTC Amendment | Extended Stay America, Inc. STAY · Entity 16197 | SalePaired Shares | 20,000 | $12.28 | $245,504.00 |
DisclosureSEC source: 0000895345-21-000516 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 60,005 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.35, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: This amended Form 4 corrects the number of Paired Shared beneficially owned directly by the reporting person following the reported transaction, which number was inadvertently misstated. The reported transaction that occurred on November 13, 2020 was a sale of Paired Shares that were beneficially owned indirectly by the reporting person through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary, rather than a sale of Paired Shares that the reporting person beneficially owned directly. F4 · ownership.nature: These Paired Shares are held through the Richard F. Wallman IRA, an individual retirement account for which he is a fiduciary. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 7,800 | Not disclosed Strike: $25.20 | Not disclosed |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · derivative · entry 6 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,800 shares Expires 2021-05-12 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 11,765 | Not disclosed Strike: $21.24 | Not disclosed |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · derivative · entry 5 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,765 shares Expires 2026-07-19 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 10,275 | Not disclosed Strike: $27.86 | Not disclosed |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · derivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,275 shares Expires 2027-07-25 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 9,907 | Not disclosed Strike: $24.49 | Not disclosed |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,907 shares Expires 2028-07-24 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | Disposition to issuerStock Option (right to buy) · Derivative | 11,691 | Not disclosed Strike: $27.84 | Not disclosed |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · derivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,691 shares Expires 2029-07-26 F2 · price: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. F2 · derivative.exercise_date: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 16:12 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | OtherOrdinary Shares, par value EUR 0.03 per share | 12,697 | $30.75 | $390,432.75 |
DisclosureSEC source: 0001235802-20-000128 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 12,697 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement). Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | PurchaseCommon Stock | 6,050 | $233.24 | $1,411,104.42 |
DisclosureSEC source: 0001127602-20-027931 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 6,050 F2 · price: This transaction was executed in multiple trades at prices ranging from $232.76 to $233.5. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 18:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | PurchaseCommon Stock | 1,150 | $232.96 | $267,902.05 |
DisclosureSEC source: 0001127602-20-027931 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,715 F1 · price: This transaction was executed in multiple trades at prices ranging from $232.7 to $233. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:18 UTC | ROPER TECHNOLOGIES INC ROP · Entity 3071 | GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053120 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,508 F1 · shares: The Reporting Person has elected to receive a portion of his cash retainer under the Roper Technologies, Inc. Director Compensation Plan in stock. Read SEC document |
| September 02, 2020 Filed Sep 2, 2020 14:40 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | PurchaseClass A Common Stock | 15,000 | $8.51 | $127,650.00 |
DisclosureSEC source: 0001775625-20-000042 · wf-form4_159905762183436.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,685 F1 · balance_after: The total number of shares of the Issuer's Class A common stock reported herein includes RSUs which were previously reported on Table II of that certain Form 4 filed by the reporting person on September 17, 2019. Further settlements of such RSUs will not be reported on further Forms 4. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 22:50 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | PurchaseClass A Common Stock | 53,000 | $7.80 | $413,400.00 |
DisclosureSEC source: 0001775625-20-000031 · wf-form4_159779099093191.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,685 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.79 to $7.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1 to Form 4. F2 · balance_after: The total number of shares of the Issuer's Class A common stock reported herein includes RSUs which were previously reported on Table II of that certain Form 4 filed by the reporting person on September 17, 2019. Further settlements of such RSUs will not be reported on further Forms 4. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 20:56 UTC | ROPER TECHNOLOGIES INC ROP · Entity 3071 | GrantCommon Stock | 957 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035561 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,502 F1 · shares: The securities reported are restricted stock units granted to the reporting person, pursuant to the Director Compensation Plan, and each restricted stock unit represents a contingent right to receive one share of Roper Technologies, Inc. common stock. The restricted stock units vest 50% on the 6-month anniversary of the grant date and 50% on the day prior to the 2021 Annual Meeting of Shareholders. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 01:09 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | GrantClass A Common Stock | 34,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035177 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,685 F1 · shares: Comprised of Restricted Stock Units ("RSUs") that represent a contingent right to receive one share of the Issuer's Class A common stock. F2 · balance_after: The total number of shares of the Issuer's Class A common stock reported herein includes RSUs which were previously reported on Table II of that certain Form 4 filed by the reporting person on September 17, 2019. Future settlements of such RSUs will not be reported on further Forms 4. Read SEC document |
| May 28, 2020 Filed May 29, 2020 20:29 UTC | Extended Stay America, Inc. STAY · Entity 16197 | GrantPaired Shares | 7,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-20-000673 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,084 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 28, 2021. Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document |
| May 11, 2020 Filed May 12, 2020 17:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 2,539 | $0.00 Strike: $164.24 | $0.00 |
DisclosureSEC source: 0001127602-20-016238 · form4.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 Underlying: Common Stock · 2,539 shares Expires 2030-05-11 F3 · derivative.exercise_date: The Stock Options become exercisable upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2020 Filed May 12, 2020 17:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 457 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016238 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,565 F2 · shares: The grant was made in lieu of director service fees for the term commencing May 6, 2020. The restricted stock units vest upon the earlier of 5/11/2021, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2020 Filed May 12, 2020 17:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 741 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016238 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,108 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2020 Filed May 12, 2020 20:11 UTC | Extended Stay America, Inc. STAY · Entity 16197 | PurchasePaired Shares | 20,000 | $10.81 | $216,224.00 |
DisclosureSEC source: 0000895345-20-000628 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,806 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.53 to $10.99, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 20:29 UTC | ROPER TECHNOLOGIES INC ROP · Entity 3071 | GrantCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023587 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,545 F1 · shares: Pursuant to an irrevocable election to accept annual director retainer in equivalent shares instead of cash. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 14:59 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | PurchaseCommon Stock | 8,000 | $4.68 | $37,439.20 |
DisclosureSEC source: 0001209191-20-019475 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 F1 · price: The shares were purchased in multiple transactions at actual sale prices ranging from $4.60 to $4.69 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2020 Filed Mar 3, 2020 16:48 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GiftOrdinary Shares, par value EUR 0.03 per share | 7,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000012 · primary_doc.xml · nonDerivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,697 F1 · balance_after: Amount reflects the cancellation of 243 ordinary shares underlying a restricted stock unit award in lieu of Board committee retainers due to a change in Board committee memberships. F2 · balance_after: Includes 5,315 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 16:48 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 20,000 | $30.29 | $605,844.00 |
DisclosureSEC source: 0001235802-20-000012 · primary_doc.xml · nonDerivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,143 F4 · shares: These shares were previously reported as directly held by the reporting person but should have been reported as indirectly held by the reporting person's wife through her IRA. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.25 to $30.35, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F1 · balance_after: Amount reflects the cancellation of 243 ordinary shares underlying a restricted stock unit award in lieu of Board committee retainers due to a change in Board committee memberships. F2 · balance_after: Includes 5,315 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 16:48 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | SaleOrdinary Shares, par value EUR 0.03 per share | 23,000 | $30.30 | $696,900.00 |
DisclosureSEC source: 0001235802-20-000012 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,143 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.29 to $30.31, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F1 · balance_after: Amount reflects the cancellation of 243 ordinary shares underlying a restricted stock unit award in lieu of Board committee retainers due to a change in Board committee memberships. F2 · balance_after: Includes 5,315 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 16:48 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GiftOrdinary Shares, par value EUR 0.03 per share | 92,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-20-000012 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,143 F1 · balance_after: Amount reflects the cancellation of 243 ordinary shares underlying a restricted stock unit award in lieu of Board committee retainers due to a change in Board committee memberships. F2 · balance_after: Includes 5,315 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 22:10 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,530 | $0.00 Strike: $52.29 | $0.00 |
DisclosureSEC source: 0001127602-20-005716 · form4.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,530 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 22:10 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3,530 | $174.29 | $615,257.82 |
DisclosureSEC source: 0001127602-20-005716 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,367 F1 · price: This transaction was executed in multiple trades at prices ranging from $174.25 to $174.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 22:10 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,530 | $52.29 | $184,583.70 |
DisclosureSEC source: 0001127602-20-005716 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 22:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,140 | $0.00 Strike: $70.29 | $0.00 |
DisclosureSEC source: 0001127602-20-005711 · form4.xml · derivative · entry 5 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,140 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 22:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,030 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001127602-20-005711 · form4.xml · derivative · entry 4 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2020-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 22:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 7,170 | $172.02 | $1,233,391.29 |
DisclosureSEC source: 0001127602-20-005711 · form4.xml · nonDerivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,367 F1 · price: This transaction was executed in multiple trades at prices ranging from $171.55 to $172.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 22:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,140 | $70.29 | $220,710.60 |
DisclosureSEC source: 0001127602-20-005711 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 22:07 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,030 | $43.39 | $174,861.70 |
DisclosureSEC source: 0001127602-20-005711 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 01:28 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | PurchaseCommon Stock | 12,000 | $9.60 | $115,200.00 |
DisclosureSEC source: 0001209191-19-058220 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 01:08 UTC | SmileDirectClub, Inc. SDC · Entity 111962 | GrantRestricted Stock Units · Derivative | 13,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-049977 · doc4.xml · derivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,043 Underlying: Class A Common Stock · 13,043 shares Expires 2029-09-16 F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Class A common stock. F2 · derivative.exercise_date: These Restricted Stock Units will vest on September 1, 2020, subject to the reporting person's continued service on the Issuer's board of directors through such date. These Restricted Stock Units will vest in full upon the consummation of a change in control subject to the reporting person's continuous service until such date. Read SEC document |
| August 12, 2019 Filed Aug 12, 2019 16:13 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | PurchaseOrdinary Shares, par value EUR 0.03 per share | 23,000 | $21.56 | $495,880.00 |
DisclosureSEC source: 0001235802-19-000100 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,291 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.39 to $21.72, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Includes 6,713 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:08 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 11,691 | $0.00 Strike: $27.84 | $0.00 |
DisclosureSEC source: 0001235802-19-000085 · primary_doc.xml · derivative · entry 3 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,691 Underlying: Ordinary Shares · 11,691 shares Expires 2029-07-26 Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:08 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 2,797 | $26.81 | $74,987.57 |
DisclosureSEC source: 0001235802-19-000085 · primary_doc.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,291 F2 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan, in lieu of retainer fees in the aggregate amount of $75,000. F3 · balance_after: Includes 6,713 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:08 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 3,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000085 · primary_doc.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,494 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 21:14 UTC | ROPER TECHNOLOGIES INC ROP · Entity 3071 | GrantCommon Stock | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036847 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,345 F1 · shares: The securities reported are restricted stock units granted to the reporting person, pursuant to the Director Compensation Plan, and each restricted stock unit represents a contingent right to receive one share of Roper Technologies, Inc. common stock. The restricted stock units vest 50% on the 6-month anniversary of the grant date and 50% on the day prior to the 2020 Annual Meeting of Shareholders. Read SEC document |
| May 30, 2019 Filed May 30, 2019 20:23 UTC | Extended Stay America, Inc. STAY · Entity 16197 | GrantPaired Shares | 5,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012422 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,806 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 30, 2020. Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 580 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019574 · form4.xml · nonDerivative · entry 2 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,367 F2 · kind: This grant was made in lieu of director service fees for the term commencing May 21, 2019. The restricted stock units vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019574 · form4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,787 F1 · kind: Consists of 1,882 unvested restricted stock units that vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| April 04, 2019 Filed Apr 4, 2019 23:22 UTC | Extended Stay America, Inc. STAY · Entity 16197 | GrantPaired Shares | 1,445 | $18.16 | $26,241.20 |
DisclosureSEC source: 0001567619-19-008446 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,173 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the first quarter of 2019. Read SEC document |
| March 15, 2019 Filed Mar 15, 2019 20:47 UTC | ROPER TECHNOLOGIES INC ROP · Entity 3071 | PurchaseCommon Stock | 500 | $326.97 | $163,482.95 |
DisclosureSEC source: 0001209191-19-019718 · doc4.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,465 Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 21:15 UTC | Extended Stay America, Inc. STAY · Entity 16197 | GrantPaired Shares | 1,607 | $16.33 | $26,242.31 |
DisclosureSEC source: 0001567619-19-000527 · doc1.xml · nonDerivative · entry 1 WALLMAN RICHARD F · CIK 0001198092 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,728 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · shares: These Paired Shares were acquired in lieu of the reporting person's quarterly cash retainer for the fourth quarter of 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.